Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rancourt

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
L'Union Medicale Du Canada|February 1, 1975
[Pemphigus and azathioprine]J Rancourt, M Lassonde
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine proteaseM Llinàs-Brunet, M Bailey, R Déziel, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitorsM Llinàs-Brunet, M Bailey, G Fazal, et al.
Journal of Medicinal Chemistry|March 3, 1999
Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domainM Llinaś-Brunet, P L Beaulieu, D R Cameron, et al.
Journal of Medicinal Chemistry|May 29, 1999
Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacementsP L Beaulieu, D R Cameron, J M Ferland, et al.
Journal of Medicinal Chemistry|July 13, 2001
Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domainJ R Proudfoot, R Betageri, M Cardozo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
L'Union Medicale Du Canada|February 1, 1975
[Pemphigus and azathioprine]J Rancourt, M Lassonde
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine proteaseM Llinàs-Brunet, M Bailey, R Déziel, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitorsM Llinàs-Brunet, M Bailey, G Fazal, et al.
Journal of Medicinal Chemistry|March 3, 1999
Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domainM Llinaś-Brunet, P L Beaulieu, D R Cameron, et al.
Journal of Medicinal Chemistry|May 29, 1999
Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacementsP L Beaulieu, D R Cameron, J M Ferland, et al.
Journal of Medicinal Chemistry|July 13, 2001
Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domainJ R Proudfoot, R Betageri, M Cardozo, et al.
Pageof 1